<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="osanctum200/PMC4727760/results/search/drugs/results.xml">
  <result pre="Drugs and Treatment Methyl jasmonate (Sigma-Aldrich, St. Louis, USA) and" exact="yohimbine" post="(Sigma, USA) were used in the study. MJ was"/>
  <result pre="pretreated intraperitonially (i.p.) with MJ (25, 50, and 100 mg/kg)," exact="yohimbine" post="(5 mg/kg), or a vehicle (10 mL/kg of 1.0%"/>
  <result pre="1). Similar effects were also produced by the reference drug," exact="yohimbine" post="(5 mg/kg, i.p) in comparison with the vehicle ("/>
  <result pre="vehicle, which further suggest anti-stress activity. In a similar manner," exact="yohimbine" post="(5 mg/kg, i.p), also shortened the period of immobility"/>
  <result pre="the vehicle, which indicates anti-stress effect ( Fig. 3). Similarly," exact="yohimbine" post="also significantly prolonged the latency to anoxic convulsions in"/>
  <result pre="[ 8, 9, 30]. The anti-fatigue and endurance-promoting effect of" exact="yohimbine" post="is related to the activation of the sympathetic nervous"/>
  <result pre="and also for the fight or flight response. In addition," exact="yohimbine" post="has been reported to promote the release of adrenaline"/>
  <result pre="response. Studies have also shown that pretreatment of animals with" exact="yohimbine" post="attenuated acute stress responses by promoting the release of"/>
 </snippets>
</snippetsTree>
